	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
ALKERMES	USD 121.55M	4.99M	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Amgen	USD 5.14B	775M	2025-12
Biogen	USD 573.2M	253.7M	2025-12
BioMarin Pharmaceutical	USD -5.26M	300.71M	2025-09
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Coherus Biosciences	USD -44.34M	9.82M	2025-03
Eli Lilly	USD 7.88B	378.1M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Glaxosmithkline	GBP 4.75B	1.52B	2025-09
Incyte	USD 414.5M	92.42M	2025-12
J&J	USD 9.52B	389M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Moderna	USD -790M	582M	2025-12
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Novartis	USD 5.88B	290M	2025-09
Pfizer	USD 6.08B	351M	2025-09
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Sanofi	EUR 4.84B	2.95B	2025-09
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
United Therapeutics	USD 436.8M	34.2M	2025-06
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09

Gilead Sciences - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.